Table 5. Diabetes Quality of Life questionnaire scores and type of treatment in baseline and follow up.
Scale | Baseline (n = 503) | Follow up (n = 464) |
---|---|---|
Satisfaction | ||
Medication* | 2.38 (0.59) | 2.12 (0.84) |
Insulin | 2.39 (0.56) | 2.21 (0.69) |
Lifestyle modification* | 2.38 (0.56) | 2.17 (0.69) |
Lifestyle modification plus oral agents* | 2.35 (0.62) | 1.21 (0.68) |
Impact | ||
Medication* | 2.36 (0.61) | 2.26 (0.63) |
Insulin | 2.39 (0.59) | 2.36 (0.59) |
Lifestyle modification* | 2.45 (0.59) | 2.25 (0.69) |
Lifestyle modification plus oral agents* | 2.37 (0.63) | 1.59 (0.68) |
Diabetes‐related worry | ||
Medication | 2.21 (0.70) | 2.14 (0.71) |
Insulin | 2.25 (0.70) | 2.20 (0.72) |
Lifestyle modification* | 2.29 (0.66) | 2.19 (0.62) |
Lifestyle modification plus oral agents* | 2.05 (0.72) | 1.48 (0.77) |
Social/vocational worry | ||
Medication | 2.20 (0.86) | 2.08 (0.86) |
Insulin | 2.29 (0.85) | 2.23 (0.86) |
Lifestyle modification* | 2.38 (0.80) | 2.23 (0.74) |
Lifestyle modification plus oral agents* | 2.38 (0.80) | 1.45 (0.81) |
Total DQOL | ||
Medication | 2.31 (0.59) | 2.15 (0.58) |
Insulin | 2.35 (0.58) | 2.25 (0.60) |
Lifestyle modification* | 2.39 (0.56) | 2.21 (0.54) |
Lifestyle modification plus oral agents* | 2.25 (0.61) | 1.44 (0.53) |
The data were adjusted for sex, educational status, age and diabetes duration. *Statistically significant according to Benjamini–Hochberg procedure. DQOL, Diabetes Quality of Life questionnaire.